Neurocrine Biosciences Inc (NBIX)
135.99
-1.77
(-1.28%)
USD |
NASDAQ |
Apr 26, 16:00
135.92
-0.07
(-0.05%)
After-Hours: 20:00
Neurocrine Biosciences 1 Year Total Returns (Daily): 32.39% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | 32.39% |
April 25, 2024 | 34.57% |
April 24, 2024 | 34.19% |
April 23, 2024 | 34.48% |
April 22, 2024 | 28.31% |
April 19, 2024 | 25.87% |
April 18, 2024 | 27.79% |
April 17, 2024 | 27.96% |
April 16, 2024 | 29.39% |
April 15, 2024 | 28.18% |
April 12, 2024 | 30.79% |
April 11, 2024 | 31.69% |
April 10, 2024 | 33.78% |
April 09, 2024 | 32.61% |
April 08, 2024 | 33.09% |
April 05, 2024 | 35.92% |
April 04, 2024 | 37.09% |
April 03, 2024 | 36.42% |
April 02, 2024 | 36.08% |
April 01, 2024 | 39.68% |
March 28, 2024 | 43.06% |
March 27, 2024 | 42.02% |
March 26, 2024 | 45.45% |
March 25, 2024 | 44.51% |
March 22, 2024 | 48.64% |
Date | Value |
---|---|
March 21, 2024 | 49.05% |
March 20, 2024 | 44.69% |
March 19, 2024 | 49.46% |
March 18, 2024 | 47.95% |
March 15, 2024 | 47.81% |
March 14, 2024 | 45.75% |
March 13, 2024 | 50.15% |
March 12, 2024 | 43.76% |
March 11, 2024 | 44.67% |
March 08, 2024 | 42.26% |
March 07, 2024 | 37.63% |
March 06, 2024 | 31.29% |
March 05, 2024 | 32.11% |
March 04, 2024 | 31.57% |
March 01, 2024 | 29.68% |
February 29, 2024 | 26.48% |
February 28, 2024 | 30.61% |
February 27, 2024 | 33.10% |
February 26, 2024 | 32.34% |
February 23, 2024 | 31.73% |
February 22, 2024 | 29.74% |
February 21, 2024 | 27.95% |
February 20, 2024 | 28.11% |
February 16, 2024 | 28.72% |
February 15, 2024 | 29.18% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-36.41%
Minimum
Jan 25 2022
63.13%
Maximum
Jun 26 2020
5.89%
Average
2.68%
Median
Oct 12 2023
1 Year Total Returns (Daily) Benchmarks
Globus Medical Inc | -12.33% |
Inspire Medical Systems Inc | -11.94% |
Amgen Inc | 16.86% |
Eli Lilly and Co | 96.56% |
Vertex Pharmaceuticals Inc | 22.94% |